Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 28.65
+1.15 (4.18%)
Apr 17, 2026, 1:53 PM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.77 billion as of April 17, 2026. Its market cap has increased by 60.81% in one year.
Market Cap
2.77B
Enterprise Value
2.65B
Revenue
849.51M
Ranking
n/a
PE Ratio
21.49
Stock Price
28.65
Market Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.77B, an increase of 117.48%. That is a compound annual growth rate of 4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.77B | 24.68% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.75B |
| Easywell Biomedicals | 5.42B |
| Orient EuroPharma | 4.11B |
| Merdury Biopharmaceutical | 3.43B |
| Maywufa Company | 2.90B |
| PhytoHealth | 2.51B |
| Johnson Chemical Pharmaceutical Works | 2.40B |
| TSH Biopharm Corporation | 1.95B |